Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
124,058,172
-
Total 13F shares
-
218,546
-
Share change
-
+30,370
-
Total reported value
-
$771,478
-
Price per share
-
$3.53
-
Number of holders
-
9
-
Value change
-
+$100,468
-
Number of buys
-
5
-
Number of sells
-
1
Institutional Holders of ADC Therapeutics SA - Common Shares (ADCT) as of Q4 2025
As of 31 Dec 2025,
ADC Therapeutics SA - Common Shares (ADCT) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
218,546 shares.
The largest 9 holders included
Florida Trust Wealth Management Co, DLK Investment Management, LLC, SG Americas Securities, LLC, Saxony Capital Management, LLC, Henrickson Nauta Wealth Advisors, Inc., WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, GAMMA Investing LLC, NISA INVESTMENT ADVISORS, LLC, and True Wealth Design, LLC.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.